RBC downgrades Merck to Sector Perform; raises PT to $150
RBC Capital downgrades Merck to Sector Perform from Outperform and raises its price target to $150 from $142, per Newsdesk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.